Determination of glycated hemoglobin in patients with advanced liver disease

doi:10.3748/wjg.v10.i15.2284

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 15

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3722)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

390

HTML

2939

Figures (1-1)

200

Tables (1-2)

193

Sum=3722

Aug 1, 2004 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (36)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Aug 1, 2004; 10(15): 2284-2286
Published online Aug 1, 2004. doi: 10.3748/wjg.v10.i15.2284

Open in New Tab Full Size Figure Download Figure

Figure 1 HbA_1c level and fructosamine concentration in pa-tients with liver disease. CC: Compensated cirrhosis; LF: Chronic hepatitis (liver fibrosis); IR: Chronic hepatitis with interferon and ribavirin treatment. Shaded areas represent the mean ± 2SD reference range for each test (HbA_1c: 4.5-5.7%; fructosamine: 200-272 μmol/L)

Citation: Lahousen T, Hegenbarth K, Ille R, Lipp RW, Krause R, Little RR, Schnedl WJ. Determination of glycated hemoglobin in patients with advanced liver disease. World J Gastroenterol 2004; 10(15): 2284-2286
URL: https://www.wjgnet.com/1007-9327/full/v10/i15/2284.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i15.2284